Literature DB >> 10480570

Sanglifehrins A, B, C and D, novel cyclophilin-binding compounds isolated from Streptomyces sp. A92-308110. I. Taxonomy, fermentation, isolation and biological activity.

J J Sanglier1, V Quesniaux, T Fehr, H Hofmann, M Mahnke, K Memmert, W Schuler, G Zenke, L Gschwind, C Maurer, W Schilling.   

Abstract

A novel class of macrolides for which the name sanglifehrins is proposed, has been discovered from actinomycete strains based on their high affinity binding for cyclophilin A (CypA), an immunophilin originally identified as a cytosolic protein binding cyclosporin A (CsA). The sanglifehrins were produced by Streptomyces sp. A92-308110. They were isolated and purified by extraction and several chromatographic, activity-guided steps. Sanglifehrins A and B exhibit a 10 to approximately 20 fold higher affinity for CypA than CsA, whereas the affinity of sanglifehrins C and D for CypA is comparable to that of CsA. Sanglifehrins exhibit a lower immunosuppressive activity than CsA when tested in the mixed lymphocyte reaction. Their in vitro activity indicates that they belong to a novel class of immunosuppressants.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10480570     DOI: 10.7164/antibiotics.52.466

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  15 in total

Review 1.  Constructing molecular complexity and diversity: total synthesis of natural products of biological and medicinal importance.

Authors:  K C Nicolaou; Christopher R H Hale; Christian Nilewski; Heraklidia A Ioannidou
Journal:  Chem Soc Rev       Date:  2012-06-28       Impact factor: 54.564

Review 2.  [Immunosuppressives to prevent rejection reactions after allogeneic corneal transplantation].

Authors:  T Lapp; P Maier; F Birnbaum; G Schlunck; T Reinhard
Journal:  Ophthalmologe       Date:  2014-03       Impact factor: 1.059

3.  Facile synthesis of a fluorescent cyclosporin a analogue to study cyclophilin 40 and cyclophilin 18 ligands.

Authors:  Steffen Gaali; Christian Kozany; Bastiaan Hoogeland; Marielle Klein; Felix Hausch
Journal:  ACS Med Chem Lett       Date:  2010-08-25       Impact factor: 4.345

4.  Cyclosporine blocks incorporation of HIV-1 envelope glycoprotein into virions.

Authors:  Elena Sokolskaja; Silvia Olivari; Madeleine Zufferey; Caterina Strambio-De-Castillia; Massimo Pizzato; Jeremy Luban
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

5.  Preclinical characterization of naturally occurring polyketide cyclophilin inhibitors from the sanglifehrin family.

Authors:  Matthew A Gregory; Michael Bobardt; Susan Obeid; Udayan Chatterji; Nigel J Coates; Teresa Foster; Philippe Gallay; Pieter Leyssen; Steven J Moss; Johan Neyts; Mohammad Nur-e-Alam; Jan Paeshuyse; Mahmood Piraee; Dipen Suthar; Tony Warneck; Ming-Qiang Zhang; Barrie Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  2011-03-07       Impact factor: 5.191

Review 6.  Molecular aspects of cyclophilins mediating therapeutic actions of their ligands.

Authors:  Andrzej Galat; Jacqueline Bua
Journal:  Cell Mol Life Sci       Date:  2010-07-04       Impact factor: 9.261

7.  Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity.

Authors:  Elena Sokolskaja; David M Sayah; Jeremy Luban
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

8.  The cyclophilin-binding agent Sanglifehrin A is a dendritic cell chemokine and migration inhibitor.

Authors:  Sabrina N Immecke; Nelli Baal; Jochen Wilhelm; Juliane Bechtel; Angela Knoche; Gregor Bein; Holger Hackstein
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

9.  Biosynthetic chlorination of the piperazate residue in kutzneride biosynthesis by KthP.

Authors:  Wei Jiang; John R Heemstra; Ry R Forseth; Christopher S Neumann; Soraya Manaviazar; Frank C Schroeder; Karl J Hale; Christopher T Walsh
Journal:  Biochemistry       Date:  2011-06-20       Impact factor: 3.162

10.  HCV NS5A and IRF9 compete for CypA binding.

Authors:  Michael Bobardt; Sam Hopkins; James Baugh; Udayan Chatterji; Felicia Hernandez; John Hiscott; Ann Sluder; Kai Lin; Philippe A Gallay
Journal:  J Hepatol       Date:  2012-08-15       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.